Psyence Biomedical share price logo

Psyence Biomedical

NASDAQ: PBM

$4.95

-0.07

(-1.49%)

Live

as on

Psyence Biomedical Stock Performance

as on October 8, 2026 at 6:06 am IST

  • Day's Low

    Day's High

    $4.90
    $5.10
    downward going graph

    1.01%

    Downside

    3.03%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.92
    $28.13
    downward going graph

    61.21%

    Downside

    468.18%

    Upside

    downward going graph

Psyence Biomedical share price movements today

Previous Close
$5.02
Open
$4.92
Volume
120.5K
Market Cap
$19.4M
Day's Low - High
$4.90 - $5.10
52 Week Low - High
$1.92 - $28.13

Psyence Biomedical Historical Returns

1 Month Return
+ 10.57 %
3 Month Return
+ 61.41 %
1 Year Return
-77.37 %
3 Year Return
0 %
5 Year Return
0 %

Psyence Biomedical Stock Fundamentals & Key Indicators

Check Psyence Biomedical market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.4M

EPS (TTM)

-1.9441

Dividend Yield

0.00%

PE Ratio (TTM)

-0.4

Industry PE ratio

-4.07

PEG Ratio

-0.00

Return On Equity TTM

-58.62%

Psyence Biomedical vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Psyence Biomedical with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$19.4MNA-0.400.00%0.00%
StrongBuy$44.5B617.67%-23.440.00%0.00%
Neutral$81.1B-39.40%-25.46-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B33.82%17.3584.86%0.51%

Stock Returns calculator for Psyence Biomedical Stock including INR - Dollar returns

The Psyence Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Psyence Biomedical investment value today

Current value as on today

₹24,330

Returns

-₹75,670

(-75.67%)

Returns from Psyence Biomedical Stock

-₹77,690 (-77.69%)

Dollar Impact

₹2,020 (+2.02%)

Indian Investors' Interest in Psyence Biomedical Stock

Search interest for Psyence Biomedical Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:1% versus previous 30 day period

Psyence Biomedical Quarterly Profit & Loss

All numbers in Millions USD

Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
0
0
0
0
0
0
-1
0
0
0
EBITDA
0
10
3
2
1
3
0
-
0
0
Interest Expense
-
-
-
-
-
-
-
-
0
0
Depreciation
-
-
-
-
-
-
-
-
-
0
Income Before Tax
0
8
2
2
0
2
0
0
0
-24
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
8
2
2
0
2
0
0
0
-24
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Psyence Biomedical Annual Profit & Loss

All numbers in Millions USD

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
Gross Profit
-
-
0
0
0
Operating Income
0
-4
-2
-3
-6
EBITDA
10
10
-51
1
-6
Interest Expense
-
-
0
0
0
Depreciation
2
-
0
0
0
Income Before Tax
8
8
-51
1
-6
Income Tax Expense
-
-
-
-
-
Net Income
8
8
-51
1
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Psyence Biomedical Quarterly Cash Flow

All numbers in Millions USD

Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Net Income
0
8
2
2
0
2
0
0
0
0
Operating Cash Flow
0
0
0
0
0
0
0
0
0
0
Investing Cash Flow
-
-255
-
-
-
-
242
0
4
0
Financing Cash Flow
0
256
-
-
-
0
-242
0
-3
0
Change in Cash
0
0
0
0
0
0
0
0
0
0

Psyence Biomedical Annual Cash Flow

All numbers in Millions USD

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
-1
0
-51
1
-6
Operating Cash Flow
0
0
-2
-3
-8
Investing Cash Flow
0
-
0
0
-4
Financing Cash Flow
-1
0
2
9
13
Change in Cash
-3
0
0
5
1

Global Institutional Holdings in Psyence Biomedical

Check out the Institutions with significant holdings in Psyence Biomedical.

Funds
Holdings
AdvisorShares
6.62%

Psyence Biomedical News & Key Events

  • img

    Today's Timeline - 05 October

    Mon, 04:30 PM

    -

    Psyence Biomedical's subsidiary TIRC partners with Benuvia to manufacture pharmaceutical-grade ibogaine in the U.S. under cGMP standards.

Insights on Psyence Biomedical

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 585.7% return, outperforming this stock by 663.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PBM stock has moved down by -8.1%

About Psyence Biomedical

Psyence Biomedical Ltd. is dedicated to advancing psychedelic medicines formulated from botanical psilocybin. The firm is actively exploring natural psilocybin as a potential therapy for adjustment disorder experienced by patients with an incurable cancer diagnosis undergoing palliative care. Its leading investigational drug, PEX010, a capsule made with naturally sourced psilocybin, is currently in a Phase IIb clinical study. This product is being developed to treat anxiety, depression, and associated conditions such as post-traumatic stress disorder (PTSD), stress, grief, and adjustment disorder, especially in a palliative care context. Psyence Biomedical has partnered with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010, utilizing psilocybin-assisted psychotherapy for adjustment disorder arising from incurable cancer. Additionally, the company holds a strategic alliance with PsyLabs for the manufacturing of Ibogaine. Headquartered in Toronto, Canada, Psyence Biomedical Ltd. functions as a subsidiary of Psyence Group Inc.
OrganisationPsyence Biomedical
Headquarters121 Richmond Street West, Toronto, ON, M5H 2K1, CA
IndustryBiotechnology
CEOJody Aufrichtig

Key Management of Psyence Biomedical

Name

Title

Mr. Jody Aufrichtig

Co-Founder, Executive Chairman & CEO

Mr. Warwick Ron Corden-Lloyd

CFO & Director

Dr. Neil Maresky M.D.

Global Head of Clinical Development

Ms. Taryn Vos

General Counsel

FAQs

What is Psyence Biomedical share price today?

Psyence Biomedical share price today is $4.95 as on . Psyence Biomedical share today touched a day high of $5.10 and a low of $4.90.

What is the 52 week high and 52 week low for Psyence Biomedical share?

Psyence Biomedical share touched a 52 week high of $28.13 on and a 52 week low of $1.92 on . Psyence Biomedical stock price today i.e. is trending at $4.95,which is 82.40% down from its 52 week high and 157.81% up from its 52 week low.

What is Psyence Biomedical's market capitalisation today?

Psyence Biomedical market capitalisation is $0.00T as on .

How to invest in Psyence Biomedical Stock (PBM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Psyence Biomedical on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Psyence Biomedical Stock (PBM) from India?

Indian investors can start investing in Psyence Biomedical (PBM) shares with as little as ₹96.775001525879 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.75 in Psyence Biomedical stock (as per the Rupee-Dollar exchange rate as on ). Based on Psyence Biomedical share’s latest price of $4.95 as on October 8, 2026 at 12:36 am IST, you will get 2.0202 shares of Psyence Biomedical. Learn more about fractional shares .